Global Prescription Weight Loss Pills market size is predicted to grow from US$ 1696 million in 2025 to US$ 3137 million in 2031; it is expected to grow at a CAGR of 10.8% from 2025 to 2031.

Global Prescription Weight Loss Pills Market Trends, Growth and Outlook 2025-31

The global Prescription Weight Loss Pills market size is predicted to grow from US$ 1696 million in 2025 to US$ 3137 million in 2031; it is expected to grow at a CAGR of 10.8% from 2025 to 2031. Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity. Rising conditions such as obesity, cardiovascular diseases, diabetes, and hypertension are increasing the revenue share of the global weight loss drugs market. Moreover, these drugs are used to maintain a healthy body weight amid growing adoption of a healthy lifestyle, thereby driving the expansion of the market revenue. Infinity Market Research newest research report, the Prescription Weight Loss Pills Industry Forecast looks at past sales and reviews total world Prescription Weight Loss Pills sales in 2024, providing a comprehensive analysis by region and market sector of projected Prescription Weight Loss Pills sales for 2025 through 2031. With Prescription Weight Loss Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Weight Loss Pills industry. This Insight Report provides a comprehensive analysis of the global Prescription Weight Loss Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Weight Loss Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Prescription Weight Loss Pills market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Weight Loss Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Weight Loss Pills. This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Weight Loss Pills market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Oral Tablets &nbsp;&nbsp;&nbsp; Oral Capsules &nbsp;&nbsp;&nbsp; Injections Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Pharmacy This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Currax Pharmaceuticals (Contrave) &nbsp;&nbsp;&nbsp; VIVUS (Qsymia) &nbsp;&nbsp;&nbsp; Novo Nordisk A/S &nbsp;&nbsp;&nbsp; Rhythm Pharmaceuticals (Imcivree) &nbsp;&nbsp;&nbsp; Eli Lilly and Company (TRICARE) &nbsp;&nbsp;&nbsp; CHEPLAPHARM (Xenical) &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Teva Pharmaceutical (Actavis) &nbsp;&nbsp;&nbsp; Haleon Group (alli) &nbsp;&nbsp;&nbsp; Sanofi (Adlyxin) &nbsp;&nbsp;&nbsp; AstraZeneca (BYDUREON BCise) Key Questions Addressed in this Report What is the 10-year outlook for the global Prescription Weight Loss Pills market? What factors are driving Prescription Weight Loss Pills market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Prescription Weight Loss Pills market opportunities vary by end market size? How does Prescription Weight Loss Pills break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Prescription Weight Loss Pills Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Prescription Weight Loss Pills by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Prescription Weight Loss Pills by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Prescription Weight Loss Pills Segment by Type &nbsp;2.2.1 Oral Tablets &nbsp;2.2.2 Oral Capsules &nbsp;2.2.3 Injections &nbsp;2.3 Prescription Weight Loss Pills Sales by Type &nbsp;2.3.1 Global Prescription Weight Loss Pills Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Prescription Weight Loss Pills Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Prescription Weight Loss Pills Sale Price by Type (2020-2025) &nbsp;2.4 Prescription Weight Loss Pills Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Pharmacy &nbsp;2.5 Prescription Weight Loss Pills Sales by Application &nbsp;2.5.1 Global Prescription Weight Loss Pills Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Prescription Weight Loss Pills Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Prescription Weight Loss Pills Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Prescription Weight Loss Pills Breakdown Data by Company &nbsp;3.1.1 Global Prescription Weight Loss Pills Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Prescription Weight Loss Pills Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Prescription Weight Loss Pills Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Prescription Weight Loss Pills Revenue by Company (2020-2025) &nbsp;3.2.2 Global Prescription Weight Loss Pills Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Prescription Weight Loss Pills Sale Price by Company &nbsp;3.4 Key Manufacturers Prescription Weight Loss Pills Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Prescription Weight Loss Pills Product Location Distribution &nbsp;3.4.2 Players Prescription Weight Loss Pills Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Prescription Weight Loss Pills by Geographic Region &nbsp;4.1 World Historic Prescription Weight Loss Pills Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Prescription Weight Loss Pills Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Prescription Weight Loss Pills Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Prescription Weight Loss Pills Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Prescription Weight Loss Pills Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Prescription Weight Loss Pills Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Prescription Weight Loss Pills Sales Growth &nbsp;4.4 APAC Prescription Weight Loss Pills Sales Growth &nbsp;4.5 Europe Prescription Weight Loss Pills Sales Growth &nbsp;4.6 Middle East & Africa Prescription Weight Loss Pills Sales Growth 5 Americas &nbsp;5.1 Americas Prescription Weight Loss Pills Sales by Country &nbsp;5.1.1 Americas Prescription Weight Loss Pills Sales by Country (2020-2025) &nbsp;5.1.2 Americas Prescription Weight Loss Pills Revenue by Country (2020-2025) &nbsp;5.2 Americas Prescription Weight Loss Pills Sales by Type (2020-2025) &nbsp;5.3 Americas Prescription Weight Loss Pills Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Prescription Weight Loss Pills Sales by Region &nbsp;6.1.1 APAC Prescription Weight Loss Pills Sales by Region (2020-2025) &nbsp;6.1.2 APAC Prescription Weight Loss Pills Revenue by Region (2020-2025) &nbsp;6.2 APAC Prescription Weight Loss Pills Sales by Type (2020-2025) &nbsp;6.3 APAC Prescription Weight Loss Pills Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Prescription Weight Loss Pills by Country &nbsp;7.1.1 Europe Prescription Weight Loss Pills Sales by Country (2020-2025) &nbsp;7.1.2 Europe Prescription Weight Loss Pills Revenue by Country (2020-2025) &nbsp;7.2 Europe Prescription Weight Loss Pills Sales by Type (2020-2025) &nbsp;7.3 Europe Prescription Weight Loss Pills Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Prescription Weight Loss Pills by Country &nbsp;8.1.1 Middle East & Africa Prescription Weight Loss Pills Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Prescription Weight Loss Pills Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Prescription Weight Loss Pills Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills &nbsp;10.3 Manufacturing Process Analysis of Prescription Weight Loss Pills &nbsp;10.4 Industry Chain Structure of Prescription Weight Loss Pills 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Prescription Weight Loss Pills Distributors &nbsp;11.3 Prescription Weight Loss Pills Customer 12 World Forecast Review for Prescription Weight Loss Pills by Geographic Region &nbsp;12.1 Global Prescription Weight Loss Pills Market Size Forecast by Region &nbsp;12.1.1 Global Prescription Weight Loss Pills Forecast by Region (2026-2031) &nbsp;12.1.2 Global Prescription Weight Loss Pills Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Prescription Weight Loss Pills Forecast by Type (2026-2031) &nbsp;12.7 Global Prescription Weight Loss Pills Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Currax Pharmaceuticals (Contrave) &nbsp;13.1.1 Currax Pharmaceuticals (Contrave) Company Information &nbsp;13.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Currax Pharmaceuticals (Contrave) Main Business Overview &nbsp;13.1.5 Currax Pharmaceuticals (Contrave) Latest Developments &nbsp;13.2 VIVUS (Qsymia) &nbsp;13.2.1 VIVUS (Qsymia) Company Information &nbsp;13.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 VIVUS (Qsymia) Main Business Overview &nbsp;13.2.5 VIVUS (Qsymia) Latest Developments &nbsp;13.3 Novo Nordisk A/S &nbsp;13.3.1 Novo Nordisk A/S Company Information &nbsp;13.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novo Nordisk A/S Main Business Overview &nbsp;13.3.5 Novo Nordisk A/S Latest Developments &nbsp;13.4 Rhythm Pharmaceuticals (Imcivree) &nbsp;13.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information &nbsp;13.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Rhythm Pharmaceuticals (Imcivree) Main Business Overview &nbsp;13.4.5 Rhythm Pharmaceuticals (Imcivree) Latest Developments &nbsp;13.5 Eli Lilly and Company (TRICARE) &nbsp;13.5.1 Eli Lilly and Company (TRICARE) Company Information &nbsp;13.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Eli Lilly and Company (TRICARE) Main Business Overview &nbsp;13.5.5 Eli Lilly and Company (TRICARE) Latest Developments &nbsp;13.6 CHEPLAPHARM (Xenical) &nbsp;13.6.1 CHEPLAPHARM (Xenical) Company Information &nbsp;13.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 CHEPLAPHARM (Xenical) Main Business Overview &nbsp;13.6.5 CHEPLAPHARM (Xenical) Latest Developments &nbsp;13.7 Pfizer &nbsp;13.7.1 Pfizer Company Information &nbsp;13.7.2 Pfizer Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.7.3 Pfizer Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Pfizer Main Business Overview &nbsp;13.7.5 Pfizer Latest Developments &nbsp;13.8 Teva Pharmaceutical (Actavis) &nbsp;13.8.1 Teva Pharmaceutical (Actavis) Company Information &nbsp;13.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Teva Pharmaceutical (Actavis) Main Business Overview &nbsp;13.8.5 Teva Pharmaceutical (Actavis) Latest Developments &nbsp;13.9 Haleon Group (alli) &nbsp;13.9.1 Haleon Group (alli) Company Information &nbsp;13.9.2 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Haleon Group (alli) Main Business Overview &nbsp;13.9.5 Haleon Group (alli) Latest Developments &nbsp;13.10 Sanofi (Adlyxin) &nbsp;13.10.1 Sanofi (Adlyxin) Company Information &nbsp;13.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Sanofi (Adlyxin) Main Business Overview &nbsp;13.10.5 Sanofi (Adlyxin) Latest Developments &nbsp;13.11 AstraZeneca (BYDUREON BCise) &nbsp;13.11.1 AstraZeneca (BYDUREON BCise) Company Information &nbsp;13.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolios and Specifications &nbsp;13.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 AstraZeneca (BYDUREON BCise) Main Business Overview &nbsp;13.11.5 AstraZeneca (BYDUREON BCise) Latest Developments 14 Research Findings and Conclusion

Report	Global Prescription Weight Loss Pills Market Growth 2025-2031
Selected License	Multi ID: LPI39085

Buyer Information

Order Summary